Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank64
3Y CAGR+44.2%
5Y CAGR-10.5%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+44.2%/yr
vs -39.5%/yr prior
5Y CAGR
-10.5%/yr
Recent acceleration
Acceleration
+83.7pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$8.34M-46.5%
2024$15.58M+18.9%
2023$13.10M+371.3%
2022$2.78M+246.6%
2021$802000.00-94.5%
2020$14.54M-29.7%
2019$20.68M-0.5%
2018$20.78M+197.5%
2017$6.98M+6.3%
2016$6.57M-